Subscribe to RSS
DOI: 10.1055/s-0029-1243291
A Novel Approach for Preventing the Development of Persistent Vasospasms after Microsurgery for the Extremities: Intermittent Topical Lidocaine Application
Publication History
Publication Date:
10 December 2009 (online)
ABSTRACT
Vasospasm is often encountered after harvesting the recipient artery in tissue transfer surgery, particularly in the extremities. Further, after anastomosis, thrombosis is a major complication arising due to vasoconstriction. Therefore, we decided to apply lidocaine topically on the recipient artery to prevent postoperative vasospasm. We had applied lidocaine topically on the recipient artery in seven patients with persistent vasospasm before the completion of the surgery. After surgery, 0.2 mL lidocaine (4%) was directly applied on the vascularized region every 15 minutes for the first 3 hours, every 30 minutes for the next 3 hours, and every 1 hour for the next 18 hours. Although four patients experienced a disturbance in the blood flow immediately after the surgery, they showed improvements after lidocaine application. In three of these four patients, vasospasm was also suspected to occur at 15 minutes after the surgery; however, topical application of lidocaine was found to be effective in these patients. Thrombosis was not observed in any case. We believe that if the site of lidocaine application is appropriate, even a small dose of low-concentration lidocaine (4%) can produce an adequate effect. Moreover, the intervals between lidocaine applications should be carefully considered.
KEYWORDS
Vasospasm - lidocaine - microsurgery - papaverine hydrochloride
REFERENCES
- 1 Ichioka S, Nakatsuka T, Ohura N, Sato Y, Harii K. Topical application of amrinone (a selective phosphodiesterase III inhibitor) for relief of vasospasm. J Surg Res. 2000; 93 149-155
- 2 Hanasono M M, Butler C E. Prevention and treatment of thrombosis in microvascular surgery. J Reconstr Microsurg. 2008; 24 305-314
- 3 Ueda Y, Hashimoto K, Tsukahara T et al.. Unphysiological cyclic contraction in damaged artery of amputated finger or limb. J Jpn Soc Surg Hand. 1995; 12 632-635
- 4 Geter R K, Winters R R, Puckett C L. Resolution of experimental microvascular spasm and improvement in anastomotic patency by direct topical agent application. Plast Reconstr Surg. 1986; 77 105-115
- 5 Richards R R, Seaber A V, Urbaniak J R. Chemically induced vasospasm: the effect of ischemia, vessel occlusion, and adrenergic blockade. Plast Reconstr Surg. 1985; 75 238-244
- 6 Derderian C A, Olivier W-AM, Baux G, Levine J, Gurtner G C. Microvascular free-tissue transfer for traumatic defects of the upper extremity: a 25-year experience. J Reconstr Microsurg. 2003; 19 455-462
- 7 Ohta I, Kawai H, Kawabata H, Masada K, Ono K. Topical use of Xylocaine for relieving vasospasm: effect of concentration. J Reconstr Microsurg. 1991; 7 205-208
- 8 Chafin J B, Wax M K, Johnstone R, Bishop D. The use of lidocaine in microvascular reconstruction. Otolaryngol Head Neck Surg. 1997; 117 93-98
- 9 Beekman W H, Dammeijer P F, Sluimers J E, Kort W J, van der Meulen J H. Improvement in blood flow and diameter of the postanastomotic rat tail artery by topical application of lidocaine in varying concentrations. Ann Plast Surg. 1990; 24 248-251
- 10 Hou S M, Liu T K, Yu H Y. Absorption of lidocaine following topical application in microvascular procedures on rabbits. J Orthop Res. 1991; 9 545-549
- 11 Beekman W H, Sluimers J E, Kort W J et al.. Resolution of experimental microvascular vasoconstriction in rats by topical application of lidocaine hydrochloride in varying concentrations. Ann Plast Surg. 1988; 21 570-575
- 12 Foldes F F, Molloy R, McNall P G et al.. Comparison of toxicity of intravenously given local anesthetic agents in man. J Am Med Assoc. 1960; 172 1493-1498
- 13 Johnstone R E, Wax M K, Bishop D J, Chafin J B. Large doses of topical lidocaine during microvascular surgery are not associated with toxic blood concentrations. Anesthesiology. 1995; 82 593-596
- 14 Ichioka S, Nakatsuka T, Ohura N, Sato Y, Harii K. Clinical use of amrinone (a selective phosphodiesterase III inhibitor) in reconstructive surgery. Plast Reconstr Surg. 2001; 108 1931-1937
Toshiya YokoyamaM.D. Ph.D.
1-5-8, Hatanodai, Shinagawa-ku
Tokyo, Japan
Email: yokotoshi0712@yahoo.co.jp